MedPath

Prospective Study: Assessing Epicardial Adipose Tissue as a Risk Factor for Major Adverse Cardiovascular Events

Not Applicable
Conditions
Health Condition 1: I778- Other specified disorders of arteries and arterioles
Registration Number
CTRI/2023/09/057294
Lead Sponsor
Dr Basavaraj GS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Adults (Age > 18 years) undergoing CTCA

2. Either sex

3. Consenting to participate

4. Willing for remote monitoring / follow up

Exclusion Criteria

Pregnancy

2. CHF – Stage D

3. Known active malignancy

4. Known CKD stage 5 or Child Pugh C

5. Known Hepatitis B / Hepatitis C

6. HIV and/or ART exposure

7. Endocrinological diseases which might affect the EAT – Cushing’s Syndrome, Acromegaly, Hyperparathyroidism, Pituitary pathologies on medications or hormone supplements, Addison’s disease,Graves’ disease

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.association between the EAT <br/ ><br>volume determined by CT and MACE events reported in patients undergoing elective coronary angiogramTimepoint: 3 years
Secondary Outcome Measures
NameTimeMethod
the correlation between patient’s volume of EAT and <br/ ><br>prior Coronary artery disease (CAD)Timepoint: 3 years
© Copyright 2025. All Rights Reserved by MedPath